If we have any methods to widen CI in parallel design with high variance drug? [RSABE / ABEL]

posted by ElMaestro  – Denmark, 2021-02-02 11:12 (133 d 20:58 ago) – Posting: # 22200
Views: 614

Hi libaiyi,

» (...) So my quesion is if we have any method to widen the CI like RSABE in cross-over study?

I don't think there is any authority generally willing to widen the acceptance range in parallel trials involving humans (they'd perhaps do it if you were studying pMDI's in vitro etc).

Pass or fail!

Complete thread:

 Admin contact
21,523 posts in 4,499 threads, 1,523 registered users;
online 6 (1 registered, 5 guests [including 2 identified bots]).
Forum time: Wednesday 09:11 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz